References
- Yousaf, H.; Jamshaid, M.; Bashir, I.; Mehmood, Y. Formulation Development of Glipizide Matrix Tablet Using Different Proportion of Natural and Semi Synthetic Polymers. Pharm. Methods 2017, 8, 183–191.
- Akbar, S.; Bhatta, R.; Rahman, M.; Hossain, M.; Bhuiyan, M.; Uddin, M. Development and Characterization of Atorvastatin Calcium Sustained Release Tablet Using Carbomer-974 and Hypromellose-15000 Cps. J. Sci. Res. 2017, 9, 247–254. DOI: https://doi.org/10.3329/jsr.v9i2.30600.
- Bibby, D. C.; Davies, N. M.; Tucker, I. G. Mechanisms by Which Cyclodextrins Modify Drug Release from Polymeric Drug Delivery Systems. Int. J. Pharm. 2000, 197, 1–11. DOI: https://doi.org/10.1016/s0378-5173(00)00335-5.
- Liu, F.-I.; Kuo, J.; Sung, K.; Hu, O. Y. Biodegradable Polymeric Microspheres for Nalbuphine Prodrug Controlled Delivery: In Vitro Characterization and in Vivo Pharmacokinetic Studies. Int. J. Pharm. 2003, 257, 23–31. DOI: https://doi.org/10.1016/s0378-5173(03)00110-8.
- Thote, A. J.; Gupta, R. B. Formation of Nanoparticles of a Hydrophilic Drug Using Supercritical Carbon Dioxide and Microencapsulation for Sustained Release. Nanomedicine: Nanotechnol., Biol. Med. 2005, 1, 85–90. DOI: https://doi.org/10.1016/j.nano.2004.12.001.
- He, P.; Davis, S. S.; Illum, L. Sustained Release Chitosan Microspheres Prepared by Novel Spray Drying Methods. J. Microencapsul. 1999, 16, 343–355. DOI: https://doi.org/10.1080/026520499289068.
- Liu, H.; Finn, N.; Yates, M. Encapsulation and Sustained Release of a Model Drug, Indomethacin, Using CO(2)-based microencapsulation. Langmuir 2005, 21, 379–385. DOI: https://doi.org/10.1021/la047934b.
- Sheth, A.; Jarowski, C. I. Use of Powdered Solutions to Improve the Dissolution Rate of Polythiazide Tablets. Drug Dev. Ind. Pharm. 1990, 16, 769–777. DOI: https://doi.org/10.3109/03639049009114908.
- Mandal, U.; Gowda, V.; Ghosh, A.; Selvan, S.; Solomon, S.; Pal, T. K. Formulation and Optimization of Sustained Release Matrix Tablet of Metformin HCl 500 mg Using Response Surface Methodology. Yakugaku Zasshi 2007, 127, 1281–1290. DOI: https://doi.org/10.1248/yakushi.127.1281.
- Robinson, J. R.; Lee, V. L. H. Controlled Drug Delivery: Fundamentals and Applications. Marcel Dekker, Inc.: New York, 1987.
- Khanfar, M.; Sheikh Salem, M.; Kaddour, F. Preparation of Sustained-Release Dosage Form of Venlafaxine HCl Using Liquisolid Technique. Pharm. Dev. Technol. 2014, 19, 103–115. DOI: https://doi.org/10.3109/10837450.2012.757785.
- Spireas, S.; Bolton, S. M. Liquisolid Systems and Methods of Preparing Same. Patent number US6423339B1, 1998.
- Natarajan, R.; Abirami, M.; Murugananthan, G. Design and Evaluation of Atorvastatin Calcium Extended Release Tablets. World J. Pharm. Pharm. Sci. 2017, 6, 1411–1423.
- Uddin, M. S.; Arafat Jakir, M.; Shalahuddin Millat, M.; Siddiqui, S. A. Formulation and Evaluation Studies of Atorvastatin Calcium Sustained Release Tablet. Pharma Tutor 2019, 7, 1–5.
- Javadzadeh, Y.; Musaalrezaei, L.; Nokhodchi, A. Liquisolid Technique as a New Approach to Sustain Propranolol Hydrochloride Release from Tablet Matrices. Int. J. Pharm. 2008, 362, 102–108. DOI: https://doi.org/10.1016/j.ijpharm.2008.06.022.
- Sanjeev, R. G.; Jarag, R. Formulation and Characterisation of Atorvastatin Calcium Liquisolid Compacts. Asian J. Pharm. Sci. 2010, 5, 50–60.
- Barzegar-Jalali, M.; Adibkia, K.; Valizadeh, H.; Shadbad, M. R. S.; Nokhodchi, A.; Omidi, Y.; Mohammadi, G.; Nezhadi, S. H.; Hasan, M. Kinetic Analysis of Drug Release from Nanoparticles. J. Pharm. Pharm. Sci. 2008, 11, 167–177. DOI: https://doi.org/10.18433/j3d59t.
- Al-Hamidi, H.; Obeidat, W. M.; Nokhodchi, A. The Dissolution Enhancement of Piroxicam in Its Physical Mixtures and Solid Dispersion Formulations Using Gluconolactone and Glucosamine Hydrochloride as Potential Carriers. Pharm. Dev. Technol. 2015, 20, 74–83. DOI: https://doi.org/10.3109/10837450.2013.871029.
- Thakur, N.; Khokra, S. L.; Sharma, D.; Thakur, N. S.; Purohit, R.; Arya, V. A Review on Pharmaceutical Application of Liquisolid Technique. American J. Pharm. Res. 2011, 1, 1–18.
- Gohel, M.; Jogani, P. D. A Review of co-Processed Directly Compressible Excipients. J. Pharm. Pharm. Sci. 2005, 8, 76–93.
- Khanfar, M.; Sheikh Salem, M.; Hawari, R. Formulation Factors Affecting the Release of Ezetimibe from Different Liquisolid Compacts. Pharm. Dev. Technol. 2013, 18, 417–427. DOI: https://doi.org/10.3109/10837450.2012.680594.
- Fahmy, R. H.; Kassem, M. A. Enhancement of Famotidine Dissolution Rate through Liquisolid Tablets Formulation: In Vitro and in Vivo Evaluation. Eur. J. Pharm. Biopharm. 2008, 69, 993–1003. DOI: https://doi.org/10.1016/j.ejpb.2008.02.017.
- Javadzadeh, Y.; Siahi-Shadbad, M.; Barzegar-Jalali, M.; Nokhodchi, A. Enhancement of Dissolution Rate of Piroxicam Using Liquisolid Compacts. Farmaco 2005, 60, 361–365. DOI: https://doi.org/10.1016/j.farmac.2004.09.005.
- Spireas, S.; Sadu, S. Enhancement of Prednisolone Dissolution Properties Using Liquisolid Compacts. Int. J. Pharm. 1998, 166, 177–188. DOI: https://doi.org/10.1016/S0378-5173(98)00046-5.
- Saeedi, M.; Akbari, J.; Morteza-Semnani, K.; Enayati-Fard, R.; Sar-Reshteh-Dar, S.; Soleymani, A. Enhancement of Dissolution Rate of Indomethacin: using Liquisolid Compacts. Iranian J. Pharm. Res. 2011, 10, 25.
- Saeedi, M.; Akbari, J.; Enayatifard, R.; Sarreshtehdar, S. Effect of Glycerin on Indomethacin Release Profile from Their Liquisolid Compacts. J. Mazandaran Uni. Med. Sci. 2009, 19, 53–61.
- Kearney, A. S.; Crawford, L. F.; Mehta, S. C.; Radebaugh, G. W. The Interconversion Kinetics, Equilibrium, and Solubilities of the Lactone and Hydroxyacid Forms of the HMG-CoA Reductase Inhibitor, CI-981. Pharm. Res. 1993, 10, 1461–1465. DOI: https://doi.org/10.1023/A:1018923325359.
- Kapure, V. J.; Pande, V. V.; Deshmukh, P. K. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique. J. Pharm. 2013, 2013, 1–9.
- Lowalekar, R.; Chauhan, L. S. In-Vitro Release Kinetics, in-Vitro Buoyancy Studies and in-Vivo Floating Behaviour of Gastro-Retentive Tablets of Ciprofloxacin and Metronidazole. J Innovations Pharm. Biol. Sci. 2016, 3, 67–72.
- Danyuo, Y.; Ani, C.; Salifu, A.; Obayemi, J.; Dozie-Nwachukwu, S.; Obanawu, V.; Akpan, U.; Odusanya, O.; Abade-Abugre, M.; McBagonluri, F. Anomalous Release Kinetics of Prodigiosin from poly-N-Isopropyl-Acrylamid Based Hydrogels for the Treatment of Triple. Negative Breast Cancer. Sci. Rep. 2019, 9, 1–14.
- Ofokansi, K. C.; Kenechukwu, F. C. Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes. ISRN Pharm. 2013, 838403, 1–8.
- Dias, R. J.; Mali, K. K.; Ghorpade, V. S.; Havaldar, V. D.; Mohite, V. R. Formulation and Evaluation of Carbamazepine Liquisolid Compacts Using Novel Carriers. IJPER 2017, 51, s69–s78. DOI: https://doi.org/10.5530/ijper.51.2s.52.